Search PubMed⌕ Search

Biomedical subjects

L Moreno

Publications and source records attributed to L Moreno.

At least 109 records · Page 6Linked to original sources
PubMed1985

Factors associated with prognosis in human breast cancer. V. The simultaneous use of estrogen and progesterone receptor measurements for prediction of short-term relapse.

Prediction of individual fate of breast cancer patients is one of the most important subjects studied because of the heterogeneity of the disease and the possibility of establishment of new therapeutic strategies. Hormone receptors have been recognized to be a valuable tool in prognosis at least in regard to short-term relapse. We have analyzed 400 patients in which hormone receptors has been determined, through stratification techniques, in 18-month and 3-year periods of disease-free interval. Clinical stage was chosen at the most important predictor in the total number of patients, lymph node status was the first predictor, estradiol receptor (ER) automatically was the second one, and the amount of receptor content had an important role in prognosis also. Inside Stage III patients ER should be the first predictor. Remarkable and independent association of progesterone receptor (PgR) content with relapse could be established. Predictive ability of ER and PgR inside lymph node status groups of patients was clearly shown. There was a remarkable difference between polar groups (lymph node-negative, ER+PgR+6% of relapse, and lymph node-positive, ER-PgR-30% of relapse) estrogen receptor status retains its predictive value, at the third year.

Breast Neoplasms↗
PubMed1983

Factors associated with prognosis in human breast cancer. III. Estradiol receptors and short term relapse.

Prognosis in breast cancer is one of the most important subjects currently studied because of the heterogeneity of the disease even inside the same clinical stage. Estrogen receptor determination in human breast cancer has been recognized as a prognostic factor since it is related to the long-term survival and disease-free interval. In a series of papers concerning prognosis in breast cancer this the third one which includes estrogen receptor determination in the multivariate analysis, because of the limitations of the clinical factor to conform stratification groups. We have analyzed the short term probability of relapse in a group of 136 patients treated for breast cancer. Multivariate stratification analysis was performed with the aid of Bintree computer program, which produces binary splits of the population according to the criterion of maximal reduction of variance and generates a binary stratification tree. Lymph node involvement is the most important prognostic factor in the probability of relapse. Patients without nodal involvement lacking estradiol receptor had 25% of relapse. It is therefore evident that estradiol receptor is a factor of prognostic value even inside node negative patients.

Breast Neoplasms↗
PubMed1983

Factors associated with prognosis in human breast cancer. II. Multivariate stratification analysis.

Prediction of the individual fate of breast cancer patient is one of the most important problems for establishment of therapeutic plans. We have analyzed the relationships of clinical factors to 3-year and 8-year survivals in a series of 400 patients treated for breast carcinoma. Multivariate stratification analysis for obtaining subgroups with different survivals was performed with the aid of Bintree, a computer program which produces binary splits of a population according to the criterion of maximal reduction of variance, and generates a binary stratification tree. Lymph node status was the major predictor for both short and long term prognosis but had no important role in the survival of patients who relapsed. Antecedent abortions were related to less relapses. Age, previous benign breast diseases, nulliparity and lactation conditioned better prognosis without association with relapse probability, indicating an association with the speed of evolution of the disseminated disease. In general clinical data were insufficient for establishment of good and bad prognosis polar groups of patients, especially in patients in which no clinical lymph node involvement was recorded.

Adult↗
PubMedDate not supplied

Neurophysiological and thermoregulatory effects of capsaicin.

The effects, in rats, of peripherally administered capsaicin were evaluated on body temperature and on brain neurophysiological activity. Capsaicin (5 mg/kg, SC) produced a rapid, long-lasting fall in body temperature. A second dose given 4.5 hr after the first showed a moderate decrement in hypothermic effect. The same dose of capsaicin caused discernible changes in deep EEG activity in the anterior hypothalamus (AH), medial habenula (HB), substantia nigra (SN), and dorsal raphe (DR). The EEG changes were more pronounced at doses of 10 and 20 mg/kg. Capsaicin in all doses modified sensory evoked responses recorded from all four brain areas. Response amplitudes after acoustic stimulation were increased at all doses of capsaicin in a dose related pattern. Photic evoked responses, like body temperature effects, showed diminished effects with second and third doses. Peripherally administered capsaicin, therefore, can affect body temperature and brain electrical activity.

Animals↗
PubMedDate not supplied

Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy.

The relationship between the pharmacokinetic behaviour and the anthelmintic efficacy of albendazole (ABZ) against benzimidazole (BZD)-resistant nematodes was studied in sheep. A micronized ABZ suspension was orally administered at two different dose levels to sheep naturally infected with BZD-resistant gastrointestinal (GI) nematodes. The experimental animals were allocated into the following groups (n = 8): (a) untreated control; (b) orally treated with ABZ at 3.8 mg/kg b.w.; and (c) orally treated with ABZ at 7.5 mg/kg b.w. Plasma samples were obtained serially over 72 h post-treatment from both treated groups and analysed by HPLC to measure the concentrations of ABZ and its sulphoxide (ABZSO) and sulphone (ABZSO(2)) metabolites. Faecal egg counts were performed prior to treatment and at the necropsy day. All experimental animals were sacrificed 10 days after treatment to perform GI worm counts. While ABZ parent drug was not recovered in the bloodstream, ABZSO and ABZSO(2) were the molecules found in plasma. ABZSO was the metabolite measured at the highest concentrations in the bloodstream for up to 36 (treatment at 3.8 mg/kg) or 60 h (treatment at 7.5 mg/kg) post-administration. There was a proportional relationship between the administered ABZ dose and the measured plasma concentrations of both ABZ metabolites. Over a 100% increment on the plasma AUC values for the anthelmintically active ABZSO metabolite was observed at the 7.5 mg/kg compared to the 3.8 mg/kg treatment. The low efficacy patterns (< 24%) observed against the GI nematodes investigated indicate a high level of resistance to ABZ given at 3.8 mg/kg an efficacious therapeutic dose rate recommended in some countries. However, the higher and prolonged plasma drug concentration measured after the 7.5 mg/kg treatment resulted in an improved efficacy pattern (estimated by both faecal egg and adult worm counts) against most of the GI nematodes studied compared to that obtained at the lower dose rate. A direct relationship between drug pharmacokinetic behaviour and anthelmintic efficacy against BZD-resistant nematodes in sheep was shown in the current work, although individual variation precluded the observation of statistically significant differences in worm counts.

Administration, Oral↗
PubMedDate not supplied

Pharmacokinetics of oxytetracycline after intramuscular administration with lidocaine in sheep, comparison with a conventional formulation.

The pharmacokinetic behaviour of oxytetracycline (OTC) was studied in 11 sheep after intravenous and intramuscular administration at a single dosage of 20 mg kg(-1) bodyweight. A conventional formulation was injected by the intravenous route and two different preparations were administered by the intramuscular route: a conventional formulation (T-100) and an aqueous solution of OTC with lidocaine (1 per cent) (OTC-L). The objective was to determine whether there are differences between both formulations in the disposition kinetics of OTC after intramuscular administration to sheep. After intravenous administration of the conventional formulation, plasma oxytetracycline concentrations were best fitted to an open two-compartment model. Mean apparent volume of distribution was 0.77+/-0.02 litre kg(-1) and the harmonic mean half-life was three hours. The OTC transfer process between central and peripheral compartments was fast and that did not influence the elimination process. After intramuscular administrations of both formulations, half-lives were longer than after intravenous administration (mean values of 14.1 and 58.2 hours for T-100 and OTC-L respectively). In both cases, a biphasic absorption, a 'flip-flop' model and a complete bioavailability were found. OTC-L provided therapeutic plasma concentrations over 0.5 microg ml(-1) (the minimum inhibitory concentration for most susceptible pathogens) for a longer period of time than T-100 (72 hours compared with 36 or 48 hours).

Absorption↗
PubMedDate not supplied

An evaluation of survey data on birthweight and prematurity status.

The 1986 experimental Demographic and Health Survey in the Dominican Republic was one of the first retrospective, population-based surveys of a developing country to collect information on prematurity status as well as birthweight. We show that the relationships among birthweight, prematurity status, and infant mortality are consistent with corresponding patterns observed in other Latin American and Caribbean countries and in developed nations. Two notable irregularities in the birthweight data are the atypically high proportion of infants weighing 4,000 grams or more, and the high mortality rates among infants with missing birthweight. Problems with the prematurity status data include an unexpectedly low proportion of premature births, an unusually small proportion of low birthweight explained by premature births, and an extremely high neonatal death rate among premature compared to term infants. Inclusion of an explicit definition of "premature" may help avert similar problems in future health surveys.

Birth Weight↗